SCHEMBL499476

SCHEMBL499476

CC1(CCBr)OCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11575260 0.90
SCHEMBL253950 0.84
SCHEMBL1165987 0.82
SCHEMBL9863975 0.80
SCHEMBL10826141 0.80
SCHEMBL9864184 0.80
SCHEMBL414007 0.79
SCHEMBL2632837 0.74
SCHEMBL713166 0.72
SCHEMBL3668462 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113861014-B Levulinic acid (ACA)13C, preparation method and application 长沙贝塔医药科技有限公司 2024-05-03 CN claimed
CN-115216003-B Star-shaped quaternary sulfonium antibacterial polyamino acid material and preparation method and application thereof 中国科学院长春应用化学研究所 2023-12-19 CN claimed
CN-115216003-A Star-shaped quaternary sulfonium antibacterial polyamino acid material and preparation method and application thereof 中国科学院长春应用化学研究所 2022-10-21 CN claimed
CN-113861014-A Levulinic acid-13C, preparation method and application 长沙贝塔医药科技有限公司 2021-12-31 CN claimed
EP-4695241-A1 THIADIAZOLONE DERIVATIVES, COMPOSITIONS AND USES THEREOF Danatlas Pharmaceuticals Co., Ltd. (CN) 2026-02-18 EP disclosed
US-20260034113-A1 THIADIAZOLONE DERIVATIVES, COMPOSITIONS AND USES THEREOF DANATLAS PHARMACEUTICALS CO LTD (CN) 2026-02-05 US disclosed
US-20260001846-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS SERVIER LAB (FR) 2026-01-01 US disclosed
US-20250206774-A1 C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS ORAGENICS, INC. 2025-06-26 US disclosed
EP-4551566-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS Les Laboratoires Servier (FR) 2025-05-14 EP disclosed
CN-119816491-A New spirocyclohexane derivatives, pharmaceutical compositions containing them and their use as anti-apoptotic inhibitors 法国施维雅药厂 2025-04-11 CN disclosed
US-20240409576-A1 -ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions- ORAGENICS, INC (US) 2024-12-12 US disclosed
WO-2024213082-A1 THIADIAZOLONE DERIVATIVES, COMPOSITIONS AND USES THEREOF DANATLAS PHARMACEUTICALS CO., LTD. (CN) 2024-10-17 WO disclosed
EP-0283309-B1 1,2-1,4 Addition reaction sequence leading to diphenylacetylenes MCNEILAB INC (US) 1995-02-15 EP disclosed
WO-1993020075-A1 8-SUBSTITUTED-N5-DEAZAPTERINS AS ANTIFOLATES THE UNIVERSITY OF SYDNEY (AU) 1993-10-14 WO disclosed
EP-0283309-A2 1,2-1,4 Addition reaction sequence leading to diphenylacetylenes McNeilab, Inc. (US) 1988-09-21 EP disclosed
US-4772755-A 1,2-1,4 addition reaction sequence leading to disubstituted acelylenes MCNEILAB, INC. (US) 1988-09-20 US disclosed
US-4517197-A ANTIDEPRESSANTS DELALANDE S.A. (FR) 1985-05-14 US disclosed
US-4434073-A Perhydrophenanthrene derivatives, their preparation, and their use in liquid-crystalline dielectrics and electro-optical display elements MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-02-28 US disclosed
US-4183858-A DECARBOXYLASE INHIBITORS MERRELL TORAUDE ET COMPAGNIE (FR) 1980-01-15 US disclosed
US-4180509-A ENZYME INHIBITORS, PARKINSON*S DISEASE MERRELL TORAUDE ET COMPAGNIE (FR) 1979-12-25 US disclosed